nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—CYP19A1—esophageal cancer	0.75	1	CbGaD
Masoprocol—IGF1R—neck—esophageal cancer	0.00857	0.116	CbGeAlD
Masoprocol—LTB4R—bronchus—esophageal cancer	0.00696	0.0939	CbGeAlD
Masoprocol—LTB4R—trachea—esophageal cancer	0.00625	0.0843	CbGeAlD
Masoprocol—IGF1R—epithelium—esophageal cancer	0.00583	0.0787	CbGeAlD
Masoprocol—IGF1R—smooth muscle tissue—esophageal cancer	0.00562	0.0759	CbGeAlD
Masoprocol—LTB4R—lung—esophageal cancer	0.00449	0.0606	CbGeAlD
Masoprocol—IGF1R—digestive system—esophageal cancer	0.00444	0.0599	CbGeAlD
Masoprocol—CYP2J2—bronchus—esophageal cancer	0.00389	0.0526	CbGeAlD
Masoprocol—IGF1R—lung—esophageal cancer	0.00371	0.05	CbGeAlD
Masoprocol—CYP2J2—trachea—esophageal cancer	0.0035	0.0472	CbGeAlD
Masoprocol—LTB4R—lymph node—esophageal cancer	0.00307	0.0414	CbGeAlD
Masoprocol—ALOX5—bronchus—esophageal cancer	0.00307	0.0414	CbGeAlD
Masoprocol—ALOX5—smooth muscle tissue—esophageal cancer	0.003	0.0405	CbGeAlD
Masoprocol—IGF1R—lymph node—esophageal cancer	0.00254	0.0342	CbGeAlD
Masoprocol—CYP2J2—lung—esophageal cancer	0.00251	0.0339	CbGeAlD
Masoprocol—ALOX5—digestive system—esophageal cancer	0.00237	0.032	CbGeAlD
Masoprocol—ALOX5—lung—esophageal cancer	0.00198	0.0267	CbGeAlD
Masoprocol—Dobutamine—CA2—esophageal cancer	0.00177	1	CrCbGaD
Masoprocol—ALOX5—lymph node—esophageal cancer	0.00135	0.0183	CbGeAlD
Masoprocol—CYP19A1—lymph node—esophageal cancer	0.000936	0.0126	CbGeAlD
Masoprocol—IGF1R—Apoptosis—TP53—esophageal cancer	0.000269	0.00155	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KMT2D—esophageal cancer	0.000268	0.00155	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—PIK3CA—esophageal cancer	0.000266	0.00153	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PDE4D—esophageal cancer	0.000263	0.00151	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKAP13—esophageal cancer	0.000261	0.0015	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—PIK3CA—esophageal cancer	0.000259	0.00149	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—ALDH2—esophageal cancer	0.000252	0.00145	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—GNG7—esophageal cancer	0.00025	0.00144	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—BCL2—esophageal cancer	0.000248	0.00143	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—esophageal cancer	0.000244	0.00141	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TP53—esophageal cancer	0.000241	0.00139	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000241	0.00139	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—ERBB2—esophageal cancer	0.000241	0.00139	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTT1—esophageal cancer	0.000239	0.00138	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADCYAP1—esophageal cancer	0.000239	0.00138	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PDE4D—esophageal cancer	0.000239	0.00137	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP2A6—esophageal cancer	0.000237	0.00136	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000236	0.00136	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KMT2D—esophageal cancer	0.000228	0.00131	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—GNG7—esophageal cancer	0.000227	0.00131	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TP53—esophageal cancer	0.000225	0.0013	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—PTGS1—esophageal cancer	0.000224	0.00129	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL2—esophageal cancer	0.00022	0.00127	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—WWOX—esophageal cancer	0.000219	0.00126	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CCND1—esophageal cancer	0.000213	0.00123	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—esophageal cancer	0.000212	0.00122	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000211	0.00121	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—BLVRB—esophageal cancer	0.00021	0.00121	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC52A3—esophageal cancer	0.00021	0.00121	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FKBP1A—esophageal cancer	0.000208	0.0012	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—ANXA1—esophageal cancer	0.000205	0.00118	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADCYAP1—esophageal cancer	0.000203	0.00117	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—WIF1—esophageal cancer	0.000203	0.00117	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL2—esophageal cancer	0.0002	0.00115	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—SST—esophageal cancer	0.000199	0.00115	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—GHRL—esophageal cancer	0.000194	0.00112	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP1B1—esophageal cancer	0.000191	0.0011	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000188	0.00108	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CSNK1A1—esophageal cancer	0.000188	0.00108	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000188	0.00108	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC52A3—esophageal cancer	0.000187	0.00108	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—BLVRB—esophageal cancer	0.000187	0.00108	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—WWOX—esophageal cancer	0.000186	0.00107	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—ANXA1—esophageal cancer	0.000186	0.00107	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—esophageal cancer	0.000184	0.00106	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000184	0.00106	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—SST—esophageal cancer	0.000181	0.00104	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ABL1—esophageal cancer	0.00018	0.00104	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CA1—esophageal cancer	0.000178	0.00103	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC10A2—esophageal cancer	0.000178	0.00103	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000178	0.00102	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FKBP1A—esophageal cancer	0.000177	0.00102	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—GHRL—esophageal cancer	0.000176	0.00101	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PFN1—esophageal cancer	0.000176	0.00101	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—esophageal cancer	0.000174	0.001	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—WIF1—esophageal cancer	0.000173	0.000996	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000173	0.000994	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000167	0.000963	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—EGFR—esophageal cancer	0.000167	0.000962	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—PIK3CA—esophageal cancer	0.000166	0.000958	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.000165	0.00095	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CA2—esophageal cancer	0.000163	0.00094	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CSNK1A1—esophageal cancer	0.00016	0.000919	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00016	0.000919	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CA1—esophageal cancer	0.000159	0.000916	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC10A2—esophageal cancer	0.000159	0.000916	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ELMO1—esophageal cancer	0.000158	0.000908	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000154	0.000889	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKAP13—esophageal cancer	0.000154	0.000887	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PLCE1—esophageal cancer	0.000152	0.000874	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ADH7—esophageal cancer	0.000152	0.000874	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00015	0.000864	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PFN1—esophageal cancer	0.000149	0.000859	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CA2—esophageal cancer	0.000146	0.000838	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—PIK3CA—esophageal cancer	0.000145	0.000835	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000142	0.000819	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000142	0.000819	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PDE4D—esophageal cancer	0.000141	0.000812	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ADH7—esophageal cancer	0.000135	0.000779	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PLCE1—esophageal cancer	0.000135	0.000779	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ELMO1—esophageal cancer	0.000134	0.000772	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GNG7—esophageal cancer	0.000134	0.000772	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000134	0.00077	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ADH1B—esophageal cancer	0.000133	0.000766	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKAP13—esophageal cancer	0.000131	0.000755	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TYMP—esophageal cancer	0.000127	0.000732	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—XIAP—esophageal cancer	0.000126	0.000723	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000124	0.000716	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP26A1—esophageal cancer	0.000124	0.000712	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000121	0.000696	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALOX15—esophageal cancer	0.000121	0.000694	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PDE4D—esophageal cancer	0.00012	0.00069	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CTNNA1—esophageal cancer	0.000119	0.000684	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ADH1B—esophageal cancer	0.000119	0.000683	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL2—esophageal cancer	0.000118	0.00068	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000117	0.000674	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000116	0.000669	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TPI1—esophageal cancer	0.000115	0.000662	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTO1—esophageal cancer	0.000115	0.000662	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GNG7—esophageal cancer	0.000114	0.000656	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TYMP—esophageal cancer	0.000113	0.000653	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PSME1—esophageal cancer	0.00011	0.000635	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PSME2—esophageal cancer	0.00011	0.000635	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP26A1—esophageal cancer	0.00011	0.000635	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALDOB—esophageal cancer	0.00011	0.000635	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ANXA1—esophageal cancer	0.00011	0.000632	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000108	0.000625	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALOX15—esophageal cancer	0.000107	0.000619	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—XIAP—esophageal cancer	0.000107	0.000615	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SST—esophageal cancer	0.000107	0.000615	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GAPDH—esophageal cancer	0.000106	0.000611	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CRABP1—esophageal cancer	0.000105	0.000606	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOTCH3—esophageal cancer	0.000104	0.000599	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GHRL—esophageal cancer	0.000104	0.000599	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTO1—esophageal cancer	0.000103	0.00059	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TPI1—esophageal cancer	0.000103	0.00059	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FBXW7—esophageal cancer	0.000102	0.00059	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CTNNA1—esophageal cancer	0.000101	0.000582	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.0001	0.000578	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL2—esophageal cancer	0.0001	0.000578	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GNG7—esophageal cancer	0.0001	0.000576	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALDOB—esophageal cancer	9.83e-05	0.000566	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—BLVRB—esophageal cancer	9.64e-05	0.000555	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC52A3—esophageal cancer	9.64e-05	0.000555	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GAPDH—esophageal cancer	9.46e-05	0.000545	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PSME2—esophageal cancer	9.38e-05	0.00054	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PSME1—esophageal cancer	9.38e-05	0.00054	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CRABP1—esophageal cancer	9.38e-05	0.00054	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALDH2—esophageal cancer	9.38e-05	0.00054	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ANXA1—esophageal cancer	9.34e-05	0.000538	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOTCH2—esophageal cancer	9.34e-05	0.000538	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SST—esophageal cancer	9.08e-05	0.000523	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GNG7—esophageal cancer	8.92e-05	0.000514	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTT1—esophageal cancer	8.92e-05	0.000514	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH3—esophageal cancer	8.85e-05	0.00051	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GHRL—esophageal cancer	8.85e-05	0.00051	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2A6—esophageal cancer	8.82e-05	0.000508	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.78e-05	0.000506	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FBXW7—esophageal cancer	8.71e-05	0.000501	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	8.62e-05	0.000497	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	8.62e-05	0.000496	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS1—esophageal cancer	8.36e-05	0.000481	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALDH2—esophageal cancer	8.36e-05	0.000481	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ENO1—esophageal cancer	8.36e-05	0.000481	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TGFBR2—esophageal cancer	8.28e-05	0.000477	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PSME1—esophageal cancer	8.23e-05	0.000474	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PSME2—esophageal cancer	8.23e-05	0.000474	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC10A2—esophageal cancer	8.2e-05	0.000472	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CA1—esophageal cancer	8.2e-05	0.000472	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTT1—esophageal cancer	7.95e-05	0.000458	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH2—esophageal cancer	7.94e-05	0.000457	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	7.94e-05	0.000457	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2A6—esophageal cancer	7.86e-05	0.000452	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SMAD4—esophageal cancer	7.84e-05	0.000451	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.83e-05	0.000451	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CA2—esophageal cancer	7.5e-05	0.000432	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS1—esophageal cancer	7.45e-05	0.000429	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ENO1—esophageal cancer	7.45e-05	0.000429	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PSME1—esophageal cancer	7.34e-05	0.000423	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PSME2—esophageal cancer	7.34e-05	0.000423	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	7.33e-05	0.000422	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.19e-05	0.000414	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP1B1—esophageal cancer	7.11e-05	0.000409	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TGFBR2—esophageal cancer	7.04e-05	0.000406	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLCE1—esophageal cancer	6.97e-05	0.000401	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADH7—esophageal cancer	6.97e-05	0.000401	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	6.92e-05	0.000398	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	6.76e-05	0.00039	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP19A1—esophageal cancer	6.68e-05	0.000385	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SMAD4—esophageal cancer	6.67e-05	0.000384	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HIF1A—esophageal cancer	6.42e-05	0.000369	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.41e-05	0.000369	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP1B1—esophageal cancer	6.33e-05	0.000365	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KDR—esophageal cancer	6.14e-05	0.000353	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADH1B—esophageal cancer	6.11e-05	0.000352	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMOX1—esophageal cancer	6.1e-05	0.000351	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.98e-05	0.000344	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP19A1—esophageal cancer	5.95e-05	0.000343	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCB1—esophageal cancer	5.85e-05	0.000337	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TYMP—esophageal cancer	5.84e-05	0.000336	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOTCH1—esophageal cancer	5.78e-05	0.000333	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP26A1—esophageal cancer	5.68e-05	0.000327	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	5.68e-05	0.000327	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALOX15—esophageal cancer	5.54e-05	0.000319	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HIF1A—esophageal cancer	5.45e-05	0.000314	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMOX1—esophageal cancer	5.43e-05	0.000313	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.33e-05	0.000307	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TPI1—esophageal cancer	5.28e-05	0.000304	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTO1—esophageal cancer	5.28e-05	0.000304	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CREBBP—esophageal cancer	5.24e-05	0.000302	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KDR—esophageal cancer	5.22e-05	0.0003	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCB1—esophageal cancer	5.22e-05	0.0003	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—esophageal cancer	5.15e-05	0.000297	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALDOB—esophageal cancer	5.06e-05	0.000292	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CA—esophageal cancer	4.92e-05	0.000283	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH1—esophageal cancer	4.91e-05	0.000283	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GAPDH—esophageal cancer	4.87e-05	0.000281	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CRABP1—esophageal cancer	4.83e-05	0.000278	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOS3—esophageal cancer	4.69e-05	0.00027	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GNG7—esophageal cancer	4.59e-05	0.000265	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CA—esophageal cancer	4.47e-05	0.000257	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CREBBP—esophageal cancer	4.46e-05	0.000257	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.42e-05	0.000255	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ERBB2—esophageal cancer	4.39e-05	0.000253	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALDH2—esophageal cancer	4.31e-05	0.000248	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTT1—esophageal cancer	4.09e-05	0.000236	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2A6—esophageal cancer	4.05e-05	0.000233	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.03e-05	0.000232	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOS3—esophageal cancer	3.99e-05	0.00023	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.94e-05	0.000227	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CREBBP—esophageal cancer	3.91e-05	0.000225	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCND1—esophageal cancer	3.88e-05	0.000223	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ENO1—esophageal cancer	3.84e-05	0.000221	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS1—esophageal cancer	3.84e-05	0.000221	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PSME2—esophageal cancer	3.78e-05	0.000218	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PSME1—esophageal cancer	3.78e-05	0.000218	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN1A—esophageal cancer	3.75e-05	0.000216	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ERBB2—esophageal cancer	3.73e-05	0.000215	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EP300—esophageal cancer	3.57e-05	0.000206	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NOS3—esophageal cancer	3.5e-05	0.000202	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CREBBP—esophageal cancer	3.49e-05	0.000201	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.3e-05	0.00019	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCND1—esophageal cancer	3.3e-05	0.00019	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP1B1—esophageal cancer	3.26e-05	0.000188	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—esophageal cancer	3.2e-05	0.000184	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN1A—esophageal cancer	3.19e-05	0.000184	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NOS3—esophageal cancer	3.12e-05	0.00018	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MYC—esophageal cancer	3.11e-05	0.000179	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—esophageal cancer	3.04e-05	0.000175	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EP300—esophageal cancer	3.03e-05	0.000175	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—esophageal cancer	2.85e-05	0.000164	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMOX1—esophageal cancer	2.8e-05	0.000161	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.75e-05	0.000158	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCB1—esophageal cancer	2.69e-05	0.000155	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—EP300—esophageal cancer	2.66e-05	0.000153	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MYC—esophageal cancer	2.64e-05	0.000152	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CA—esophageal cancer	2.64e-05	0.000152	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—esophageal cancer	2.59e-05	0.000149	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—esophageal cancer	2.55e-05	0.000147	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—EP300—esophageal cancer	2.37e-05	0.000137	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CA—esophageal cancer	2.24e-05	0.000129	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—esophageal cancer	2.17e-05	0.000125	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.03e-05	0.000117	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CA—esophageal cancer	1.97e-05	0.000113	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CREBBP—esophageal cancer	1.8e-05	0.000103	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CA—esophageal cancer	1.76e-05	0.000101	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NOS3—esophageal cancer	1.61e-05	9.26e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—esophageal cancer	1.47e-05	8.47e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—EP300—esophageal cancer	1.22e-05	7.04e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CA—esophageal cancer	9.05e-06	5.21e-05	CbGpPWpGaD
